CRL · 8-K · 20260805PR000115
Income Tax Rate Changes
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 75 · Surprise 64 · In source text
Second-quarter income-tax provision increased to $53.9 million from $18.7 million despite pretax income declining to $53.2 million from $71.4 million. The higher provision contributed to a $0.8 million net loss, compared with $52.7 million of net income in the prior-year quarter. Management expects second-quarter deferred-compensation investment gains to be largely offset by a higher tax rate, producing a negligible net impact on full-year non-GAAP EPS. The company reduced 2026 GAAP EPS guidance to $3.05-$3.35 from $5.35-$5.85, primarily because of divestiture losses, while non-GAAP EPS guidance increased to $11.15-$11.45.
Key facts
- Company expects the Q2 investment gains associated with the deferred compensation plan will be largely offset by a higher tax rate for the year, resulting in a negligible net impact to non-GAAP EPS. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | unclear | probable | — | Company expects the Q2 investment gains associated with the deferred compensation plan will be largely offset by a higher tax rate for the… |